Ischemic cerebrovascular disease
Conditions
Interventions
Experience group:Stem cells
Control:Placebo + basal treatment
Sponsors
Taihe Hospital of Shiyan, Hubei Province
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Among the age of 18~75 years old, gender not limited; Participants with cerebral infarction, the basal ganglia ischemic cerebrovascular disease onset time in two weeks and confirmed by MRI, NIHSS score of 4-12 points; Without serious heart, liver, kidney and the blood coagulation dysfunction; The informed consent signed by voluntary participants or their legal guardian subjects in accordance with the participants' willingness.
Exclusion criteria
Exclusion criteria: Have a history of serious drug allergy or allergic constitution; Have a serious cardiovascular, liver, kidney disease; With more severe respiratory, endocrine system diseases; With serious blood system diseases; With known or suspected malignant tumor; With difficult to control the infection; With a severe brain injury, resulting in severe neurological defects or psychiatric disease; Serum HIV antibody, syphilis antibody positive; Alcoholism and drug abusers; Pregnancy or may pregnancy and lactation women; Doctors think there are other reasons can not be included in the stem cell therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIHSS;ADL;MRI;MRS;MRA;3D-ALS of brain; | — |
Contacts
Public ContactYunfu Wang
Outcome results
None listed